Clinical trial
Acetazolamide for Respiratory Failure in Combination With Metabolic Alkalosis
NCT00222534 is registered in ClinicalTrials.gov with University of Oslo School of Pharmacy as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Acetazolamide for Respiratory Failure in Combination With Metabolic Alkalosis
- Lead sponsor
- University of Oslo School of Pharmacy
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2002
- Completion date
- December 31, 2009
- Enrollment
- 70 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.